Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value: $1.236B (98.2% shares, 1.8% debt)

Holdings (15)

VTI VANGUARD INDEX FDS 25.5%

Value $316M Shares 2,979,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 21.4%

Value $265M Shares 5,901,819 Est. Cost $32.35 Unrealized —

INGN INOGEN INC 9.0%

Value $111M Shares 3,549,320 Est. Cost $17.78 Unrealized +36.3%

VGK VANGUARD INTL EQUITY INDEX F 8.9%

Value $110M Shares 2,101,000 Est. Cost $45.01 Unrealized —

— ALDER BIOPHARMACEUTICALS INC 7.5%

Value $93.12M Shares 3,201,183 Est. Cost $20.07 Unrealized —

— NEVRO CORP 6.9%

Value $84.88M Shares 2,194,841 Est. Cost $38.67 Unrealized —

— OTONOMY INC 5.9%

Value $72.49M Shares 2,175,025 Est. Cost $24.00 Unrealized —

— TETRAPHASE PHARMACEUTICALS INC 4.7%

Value $58.57M Shares 1,475,000 Est. Cost $23.73 Unrealized —

— FLEXION THERAPEUTICS INC 3.7%

Value $46.1M Shares 2,283,131 Est. Cost $17.27 Unrealized —

— Wright Medical Group 1.8%

Value $22.56M Shares 4,720,065 Est. Cost $2.50 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 1.4%

Value $17.65M Shares 1,516,387 Est. Cost $24.08 Unrealized -40.4%

— TOKAI PHARMACEUTICALS INC 1.4%

Value $17.38M Shares 1,178,992 Est. Cost $14.46 Unrealized —

— AERIE PHARMACEUTICALS INC 1.0%

Value $12.25M Shares 419,652 Est. Cost $29.19 Unrealized —

— INTERSECT ENT INC 0.5%

Value $6.492M Shares 350,000 Est. Cost $15.50 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.2%

Value $2.519M Shares 127,563 Est. Cost $14.68 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$316M	25.5%	$57.39	—	TOTAL STK MKT	922908769
—	OPHTHOTECH CORP	5,901,819	$265M	21.4%	$32.35	—	COM	683745103
INGN	INOGEN INC	3,549,320	$111M	9.0%	$17.78	+36.3%	COM	45780L104
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$110M	8.9%	$45.01	—	FTSE EUROPE ETF	922042874
—	ALDER BIOPHARMACEUTICALS INC	3,201,183	$93.12M	7.5%	$20.07	—	COM	014339105
—	NEVRO CORP	2,194,841	$84.88M	6.9%	$38.67	—	COM	64157F103
—	OTONOMY INC	2,175,025	$72.49M	5.9%	$24.00	—	COM	68906L105
—	TETRAPHASE PHARMACEUTICALS INC	1,475,000	$58.57M	4.7%	$23.73	—	COM	88165N105
—	FLEXION THERAPEUTICS INC	2,283,131	$46.1M	3.7%	$17.27	—	COM	33938J106
—	Wright Medical Group	4,720,065	$22.56M	1.8%	$2.50	—	Contingent Value Rights	98235T115
AKBA	AKEBIA THERAPEUTICS INC	1,516,387	$17.65M	1.4%	$24.08	-40.4%	COM	00972D105
—	TOKAI PHARMACEUTICALS INC	1,178,992	$17.38M	1.4%	$14.46	—	COM	88907J107
—	AERIE PHARMACEUTICALS INC	419,652	$12.25M	1.0%	$29.19	—	COM	00771V108
—	INTERSECT ENT INC	350,000	$6.492M	0.5%	$15.50	—	COM	46071F103
XENE	XENON PHARMACEUTICALS INC	127,563	$2.519M	0.2%	$14.68	0.0%	COM	98420N105